These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 13810954)

  • 21. Comparative studies of the in vivo toxin neutralization and the in vitro Vero cell assay methods for use in potency testing of diphtheria component in combined vaccines/toxoids. 1: Standardization of a modified Vero cell assay for toxin-antitoxin titration of immunized guinea-pig sera.
    Dular U
    Biologicals; 1993 Mar; 21(1):53-9. PubMed ID: 8217118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An approach to establishing diphtheria potency specifications for diphtheria and tetanus toxoid, acellular pertussis vaccine formulations linked to clinical efficacy.
    Brock B; Mckee B
    Biologicals; 1999 Jun; 27(2):183. PubMed ID: 10600210
    [No Abstract]   [Full Text] [Related]  

  • 23. Standardization of diphtheria and tetanus toxoids.
    PRIGGE R
    Bull World Health Organ; 1953; 9(6):843-9. PubMed ID: 13141136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Potency on Diphtheria and Tetanus Toxoid for Adult Vaccines by In Vivo Toxin Neutralization Assay Using National Reference Standards.
    Choi CW; Moon JH; Kim JO; Yoo SH; Kim HG; Kim JH; Park TJ; Kim SS
    Osong Public Health Res Perspect; 2018 Oct; 9(5):278-282. PubMed ID: 30402384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid?
    Scheifele D; Barreto L; Meekison W; Guasparini R; Friesen B
    CMAJ; 1993 Oct; 149(8):1105-12. PubMed ID: 8221449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.
    Halperin SA; King J; Law B; Mills E; Willems P
    Clin Infect Dis; 1999 May; 28(5):995-1001. PubMed ID: 10452624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of DTP and Haemophilus influenzae type b conjugate vaccines can affect laboratory evaluation of potency and immunogenicity.
    Redhead K; Sesardic D; Yost SE; Attwell AM; Watkins J; Hoy CS; Plumb JE; Corbel MJ
    Biologicals; 1994 Dec; 22(4):339-45. PubMed ID: 7779360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potency control of tetanus and diphtheria toxoids, adsorbed, produced in Bulgaria.
    Vrancheva S; Vulchev V; Bachev S
    Prog Immunobiol Stand; 1970; 4():548-52. PubMed ID: 5482199
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunological response in the infant vaccinated with quadruple DPT-polio vaccine].
    MORRONE G; NUNZIATA B; PICCIOTTO L
    Riv Ist Sieroter Ital; 1959; 34():321-9. PubMed ID: 14424398
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunitary response of the infant vaccinated with quadruple DPT-polio vaccine].
    MORRONE G; NUNZIATA B; PICCIOTTO L
    Riv Ist Sieroter Ital; 1959; 34():321-9. PubMed ID: 14424397
    [No Abstract]   [Full Text] [Related]  

  • 31. Validation of the toxin-binding inhibition (ToBI) test for the estimation of the potency of the tetanus toxoïd component in vaccines.
    van der Gun J; Akkermans A; Hendriksen C; van de Donk H
    Dev Biol Stand; 1996; 86():199-206. PubMed ID: 8785949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serological assays as alternatives to the Ph Eur challenge test for batch release of tetanus vaccines for human use.
    Winsnes R; Hendriksen C; Sesardic D; Akkermans A; Daas A
    Dev Biol Stand; 1999; 101():277-88. PubMed ID: 10566802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Collaborative study for the establishment of tetanus vaccine (adsorbed) Third International Standard and European Pharmacopoeia Biological Reference Preparation batch no. 2.
    Sesardic D; Winsnes R; Rigsby P; Gaines-Das R
    Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):45-72. PubMed ID: 11705100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection.
    Heininger U; Stehr K; Christenson P; Cherry JD
    Clin Infect Dis; 1999 Mar; 28(3):602-4. PubMed ID: 10194085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A placebo-controlled trial of a pertussis-toxoid vaccine.
    Trollfors B; Taranger J; Lagergård T; Lind L; Sundh V; Zackrisson G; Lowe CU; Blackwelder W; Robbins JB
    N Engl J Med; 1995 Oct; 333(16):1045-50. PubMed ID: 7675047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combined diphtheria-tetanus-pertussis vaccine. II. Postvaccinal reactions and immunological response in vaccinated children].
    CALALB G
    Arch Roum Pathol Exp Microbiol; 1961 Dec; 20():667-76. PubMed ID: 13875655
    [No Abstract]   [Full Text] [Related]  

  • 39. Vero cell assay validation of an alternative to the Ph. Eur. diphtheria potency tests.
    Gommer AM
    Dev Biol Stand; 1996; 86():217-24. PubMed ID: 8785952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The determination of the protective potency of the diphtheria component in combined vaccines by the indirect hemagglutination (IHA) method].
    Unver SD; Ozcengiz E
    Mikrobiyol Bul; 1990 Oct; 24(4):327-35. PubMed ID: 2287290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.